The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 40.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 3.00 (7.50%)
Open: 41.50
High: 41.50
Low: 41.50
Prev. Close: 41.50
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Company Fundraising - PulsiV Solar Ltd

27 Oct 2015 07:00

RNS Number : 4849D
Frontier IP Group plc
27 October 2015
 

 

 

AIM: FIPP

27 October 2015

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

Uplift in Frontier IP's portfolio valuation following completion of PulsiV fundraising

 

 

Frontier IP, which specialises in the commercialisation of intellectual property, is pleased to announce a significant uplift in the value of its portfolio company PulsiV Solar Ltd ("PulsiV Solar"), following the successful completion of PulsiV Solar's first fundraising.

 

PulsiV Solar has received commitments totalling £0.5 million which will result in Frontier IP's holding in PulsiV Solar being revalued to show an uplift of over £0.87 million. The increase will be partially recognised in Frontier IP's financial statements for the year ended 30 June 2015, with the balance expected to be recognised in the Group's interim statements for the six months ending 31 December 2015. The fundraise values PulsiV Solar at £5 million with Frontier IP retaining an 18.9% holding in the issued share capital.

 

PulsiV Solar, which spun-out from Plymouth University, has developed new technology which significantly improves the energy efficiency of photovoltaic solar panels. It does this by maximising the energy generated by the system's inverters, which convert the energy harvested for supply to the grid. The global solar inverter market is forecast to be valued at approximately $7 billion in 2015, according to GTM Research. Results from PulsiV Solar's first prototype show a typical increase of up to 30% in energy generation when compared with conventional inverter technology. The technology can be integrated into new systems or retrofitted to existing solar panels.

 

This fundraising will allow PulsiV Solar to accelerate product development, enabling further prototyping and testing in preparation for the initial production of micro-inverters containing its technologies.

 

Dr. Mohamed Zaki Ahmed, Chief Technology Officer of PulsiV Solar, said:

 

"Frontier IP has played a key role in enabling us to successfully close our first fundraising. Frontier is also leveraging its relationships in the energy sector to open up further opportunities as we look to realise the commercial potential of PulsiV Solar's technology. We are delighted to have Frontier IP's active involvement in the commercialisation process and look forward to the next stage in our growth."

 

Neil Crabb, Chief Executive of Frontier IP, said:

 

"The technology being developed by our portfolio company PulsiV Solar, has the potential to drive significant gains in the energy efficiency of solar panels and other photovoltaic systems. We have been delighted to assist with the Company's first funding round and will continue to deploy our energy sector experience to take this ground-breaking technology to market."

 

Enquiries

 

Frontier IP Group Plc

T: 0131 240 1251

Neil Crabb, Chief Executive

Company website: www.frontierip.co.uk

 

Cantor Fitzgerald Europe

(Nominated Adviser and Joint Broker)

T: 020 7894 7000

David Foreman, Catherine Leftley, Corporate Finance

David Banks, Corporate Broking

Peterhouse Corporate Finance Limited

(Joint Broker)

T: 020 7469 0935

Lucy Williams

Kreab

T: 020 7074 1800

Robert Speed, Matthew Jervois

 

 

Notes to Editor:

 

About Frontier IP Group plc

www.frontierip.co.uk.

 

Frontier IP specialises in assisting institutions and companies in the commercialisation and exploitation of their intellectual property. It establishes formal and informal relationships with sources of exploitable IP, principally universities. Its core business is building and growing a portfolio of equity stakes in spin-out companies by taking an active involvement in the commercialisation and funding of these businesses. Frontier IP currently has seventeen companies in its portfolio, which exploit IP from a range of institutions.

About PulsiV Solar Limited

 

PulsiV Solar was set up by Dr. Mohamed Zaki Ahmed, Plymouth University and Frontier IP Group PLC and develops a novel inverter technology to improve power take-off from photovoltaic solar panels. PulsiV Solar's technology aims to maximise the energy generated by solar inverters and is a potentially disruptive technology, capable of retro-fit. The PulsiV Solar team is based at Plymouth University, with key strategic and support functions being provided by Frontier IP Group plc.

Dr Mohammed Zaki Ahmed, Chief Technology Officer of PulsiV Solar, has led the development of this breakthrough technology and has a successful track record with other innovations, including train collision avoidance systems, which are now widely adopted across the world.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDQLFLEBFXFBQ
Date   Source Headline
15th Nov 20184:08 pmRNSDirector Dealing
15th Nov 201812:37 pmRNSGrant of Options
15th Nov 201810:05 amRNSExscientia acquires Kinetic Discovery
15th Nov 20189:30 amRNSPlacing to raise £2.49 million
15th Nov 20189:25 amRNSFinal Results
30th Oct 20187:00 amRNSSecond Portuguese spin out: Des Solutio
19th Oct 20187:00 amRNSMolendotech signs collaboration agreement with G's
5th Oct 20187:00 amRNSDIT hails Frontier IP's Portuguese success
27th Sep 20187:00 amRNSChange of Adviser
26th Sep 20185:12 pmRNSDirector Declaration
24th Sep 20182:30 pmRNSHolding(s) in Company
20th Sep 20187:00 amRNSAmprologix to develop new antibiotics with Ingenza
18th Sep 20181:56 pmRNSAlusid raises £1.34m to scale up manufacturing
17th Sep 20187:00 amRNSAB Sugar Head of Innovation joins Frontier IP
30th Aug 201812:39 pmRNSHolding(s) in Company
15th Aug 20187:00 amRNSTVG awarded £50,000 anti-bacterial vaccine grant
7th Aug 20187:00 amRNSPortfolio news - first Portuguese spin out
6th Aug 20187:00 amRNSFieldwork Robotics agreement with Hall Hunter
2nd Aug 20187:00 amRNSFrontier IP partners with UK DIT in Portugal
16th Jul 20187:00 amRNSTarsis Collaboration with Crop-Protection Company
11th Jul 20187:00 amRNSInnovate UK grant for Pulsiv Solar
19th Jun 20187:00 amRNSCambridge Material Testing Solutions
15th May 20187:00 amRNSPalintest launches Molendotech bathing water test
18th Apr 20184:09 pmRNSHolding(s) in Company
9th Apr 20188:25 amRNSIncreased Equity Holding in Fieldwork Robotics
27th Mar 20187:00 amRNSHALF-YEAR RESULTS, 6 MONTHS TO 31 DECEMBER 2017
26th Mar 20187:00 amRNSTeam Expansion and London Office
19th Feb 20187:00 amRNSPortfolio News - Molendotech Secures First Funding
29th Jan 20187:00 amRNSCapital Markets Day
29th Jan 20187:00 amRNSPortfolio News - Molendotech Collaboration
18th Dec 20177:00 amRNSCapital Markets Day
7th Dec 201711:50 amRNSResult of AGM
8th Nov 20177:00 amRNSPosting of Annual Report and Notice of AGM
30th Oct 20175:15 pmRNSHolding(s) in Company
30th Oct 201712:00 pmRNSPortfolio News PulsiV Granted Two US Patents
24th Oct 20177:00 amRNSFinal Results
9th Oct 20177:00 amRNSExscientia Wins Emerging Biotech Company Award
28th Sep 20177:00 amRNSExscientia announces investment from Evotec
25th Sep 20171:12 pmRNSHolding(s) in Company
20th Sep 20177:00 amRNSAlusid extends range at London Design Festival
7th Sep 20177:00 amRNSCSI launches novel sensor system at IFA Berlin
8th Aug 20177:00 amRNSNew Portfolio Company - The Vaccine Group
28th Jul 20173:26 pmRNSHolding(s) in Company
20th Jul 20177:00 amRNSPortfolio News- Nandi Proteins Limited Fundraising
11th Jul 20174:38 pmRNSHolding(s) in Company
5th Jul 20177:00 amRNSNew Portfolio Company - MolEndoTech
3rd Jul 20177:00 amRNSExscientia announces major GSK collaboration
11th May 20177:00 amRNSGrant of Options
9th May 201712:05 pmRNSRoyal Society of Chemistry Nominations
9th May 201711:25 amRNSExscientia announces major Sanofi collaboration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.